서브메뉴
검색
Incentivizing Evidence-Based Care: Policy Levers and Delivery-System Response
Incentivizing Evidence-Based Care: Policy Levers and Delivery-System Response
상세정보
- 자료유형
- 학위논문 서양
- 최종처리일시
- 20260202103035
- ISBN
- 9798286424771
- DDC
- 616.2414
- 저자명
- Beetham, Tamara.
- 서명/저자
- Incentivizing Evidence-Based Care: Policy Levers and Delivery-System Response
- 발행사항
- [Sl] : Yale University, 2025
- 발행사항
- Ann Arbor : ProQuest Dissertations & Theses, 2025
- 형태사항
- 85 p
- 주기사항
- Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
- 주기사항
- Advisor: Busch, Susan.
- 학위논문주기
- Thesis (Ph.D.)--Yale University, 2025.
- 초록/해제
- 요약This dissertation examines how state and federal policies shape the addiction treatment landscape, focusing on how the treatment delivery system responds to policy changes. Through three chapters, I evaluate policy tools designed to expand access to life-saving yet underutilized services and their potential to mitigate or reinforce disparities. The first two chapters analyze a Medicaid policy change that allowed states to access previously restricted funding, contingent on improving their addiction treatment systems. Chapter one finds that improvements in access and quality were primarily driven by facility turnover-new facility openings and closures-rather than changes within existing facilities. Chapter two assesses the geographic distribution of these improvements, showing that while access to Medicaid-accepting residential treatment facilities expanded broadly, quality improvements were concentrated in areas with fewer Black residents, highlighting persistent structural inequities. The third chapter evaluates the role of regulatory flexibility in expanding access to evidence-based addiction treatment services, focusing on provider responses to telehealth policy changes during the COVID-19 pandemic. Findings indicate that providers found telehealth more effective than expected and strongly supported keeping the temporarily loosened telehealth restrictions for opioid use disorder treatment. Together, these chapters provide new evidence on how financial and regulatory incentives shape provider behavior and market composition in addiction treatment. The findings underscore the need for carefully designed policies that not only expand access but also ensure equitable improvements in care quality. This research informs broader discussions on how Medicaid policy, payment incentives, and regulatory policy can be leveraged to promote equitable delivery of evidence-based addiction treatment.
- 키워드
- COVID-19
- 키워드
- Federal policies
- 기타저자
- Yale University Public Health
- 기본자료저록
- Dissertations Abstracts International. 86-12B.
- 전자적 위치 및 접속
- 로그인 후 원문을 볼 수 있습니다.
MARC
008260126s2025 us c eng d■001000017356788
■00520260202103035
■006m o d
■007cr#unu||||||||
■020 ▼a9798286424771
■035 ▼a(MiAaPQ)AAI31846250
■040 ▼aMiAaPQ▼cMiAaPQ
■0820 ▼a616.2414
■1001 ▼aBeetham, Tamara.
■24510▼aIncentivizing Evidence-Based Care: Policy Levers and Delivery-System Response
■260 ▼a[Sl]▼bYale University▼c2025
■260 1▼aAnn Arbor▼bProQuest Dissertations & Theses▼c2025
■300 ▼a85 p
■500 ▼aSource: Dissertations Abstracts International, Volume: 86-12, Section: B.
■500 ▼aAdvisor: Busch, Susan.
■5021 ▼aThesis (Ph.D.)--Yale University, 2025.
■520 ▼aThis dissertation examines how state and federal policies shape the addiction treatment landscape, focusing on how the treatment delivery system responds to policy changes. Through three chapters, I evaluate policy tools designed to expand access to life-saving yet underutilized services and their potential to mitigate or reinforce disparities. The first two chapters analyze a Medicaid policy change that allowed states to access previously restricted funding, contingent on improving their addiction treatment systems. Chapter one finds that improvements in access and quality were primarily driven by facility turnover-new facility openings and closures-rather than changes within existing facilities. Chapter two assesses the geographic distribution of these improvements, showing that while access to Medicaid-accepting residential treatment facilities expanded broadly, quality improvements were concentrated in areas with fewer Black residents, highlighting persistent structural inequities. The third chapter evaluates the role of regulatory flexibility in expanding access to evidence-based addiction treatment services, focusing on provider responses to telehealth policy changes during the COVID-19 pandemic. Findings indicate that providers found telehealth more effective than expected and strongly supported keeping the temporarily loosened telehealth restrictions for opioid use disorder treatment. Together, these chapters provide new evidence on how financial and regulatory incentives shape provider behavior and market composition in addiction treatment. The findings underscore the need for carefully designed policies that not only expand access but also ensure equitable improvements in care quality. This research informs broader discussions on how Medicaid policy, payment incentives, and regulatory policy can be leveraged to promote equitable delivery of evidence-based addiction treatment.
■590 ▼aSchool code: 0265.
■653 ▼aCOVID-19
■653 ▼aAddiction treatment
■653 ▼aFederal policies
■653 ▼aPayment incentives
■690 ▼a0769
■690 ▼a0501
■71020▼aYale University▼bPublic Health.
■7730 ▼tDissertations Abstracts International▼g86-12B.
■790 ▼a0265
■791 ▼aPh.D.
■792 ▼a2025
■793 ▼aEnglish
■85640▼uhttp://www.riss.kr/pdu/ddodLink.do?id=T17356788▼nKERIS▼z이 자료의 원문은 한국교육학술정보원에서 제공합니다.
